{"nct_id":"NCT00299494","title":"Study Evaluating Inotuzumab Ozogamicin [CMC-544] Administered In Combination With Rituximab In Subjects With Non-Hodgkin's Lymphoma (NHL)","status":"COMPLETED","status_verified_date":"2018-02","start_date":"2006-05-04","start_date_type":"ACTUAL","primary_completion_date":"2014-05-19","primary_completion_date_type":"ACTUAL","completion_date":"2014-06-02","completion_date_type":"ACTUAL","phases":["PHASE1","PHASE2"],"tickers":["PFE"]}